Bulk Ethyl 2-Oxo-4-Phenylbutyrate Handling For Lisinopril Lines

Cold Chain Logistics for Ethyl 2-oxo-4-phenylbutyrate: Mitigating Viscosity Spikes and Solidification in Winter Transit

In the synthesis of lisinopril, ethyl 2-oxo-4-phenylbutyrate serves as a critical API precursor. However, its physical behavior under cold conditions presents a non-standard challenge that can disrupt manufacturing lines. Field experience shows that at temperatures below 5°C, this compound exhibits a significant viscosity increase, and near 0°C, it can partially solidify, forming a slush-like consistency. This is not a standard specification but an observed edge-case behavior that plant managers must account for. If drums are allowed to freeze, the material becomes difficult to pump and may require extended thawing periods, delaying reactor charging. To mitigate this, temperature-controlled logistics are essential. We recommend maintaining a transport temperature range of 15–25°C, using refrigerated containers with heating capabilities during winter months. This ensures the product remains in a free-flowing liquid state upon arrival, ready for immediate use in your lisinopril manufacturing process.

For procurement teams, understanding this behavior is crucial when planning inventory during cold seasons. A drop-in replacement from NINGBO INNO PHARMCHEM offers identical performance to reference standards, but without proactive thermal management, even the best product can cause bottlenecks. Our technical team provides guidance on storage and handling to prevent such issues. For more on how our product matches established standards, see our article on drop-in replacement for LGC TRC-E925385.

Insulated Packaging and Thermal Protection Strategies for 25kg Drum Shipments of Ethyl 2-oxo-4-phenylbutyrate

Standard packaging for ethyl 2-oxo-4-phenylbutyrate includes 25kg HDPE drums, but for winter shipments, additional thermal protection is non-negotiable. We employ insulated pallet covers and phase-change materials (PCMs) to buffer against ambient temperature fluctuations. Each drum is sealed under nitrogen to prevent moisture ingress, which can lead to hydrolysis and impurity formation. The packaging is designed to withstand the rigors of international freight while maintaining product integrity.

Critical Storage and Handling Note: Store in a cool, dry place away from direct sunlight. Recommended storage temperature: 15–25°C. Avoid freezing. If crystallization occurs, gently warm the sealed drum to 25–30°C and agitate until homogeneous. Do not use open flame or direct steam. Always refer to the batch-specific COA for detailed specifications.

For bulk shipments, we also offer 210L steel drums and IBC totes, all with appropriate thermal labeling. Our logistics partners are experienced in pharmaceutical chemical transport, ensuring compliance with hazmat regulations. This attention to packaging detail is what makes us a reliable partner for lisinopril manufacturers. For German-speaking clients, we have a dedicated resource on Drop-In-Ersatz für LGC TRC-E925385.

Impact of Thermal Cycling on Trace Impurity Phase Separation in Ethyl 2-oxo-4-phenylbutyrate During Bulk Transport

Repeated thermal cycling—common in long-haul shipments crossing climate zones—can induce phase separation of trace impurities in ethyl 2-oxo-4-phenylbutyrate. This is a field-observed phenomenon not typically covered in standard COAs. Impurities such as residual 2-oxo-4-phenylbutanoic acid or ethyl ester homologs may concentrate in the lower layer if the product partially solidifies and then remelts unevenly. This can lead to off-spec material at the point of use, affecting the yield and purity of the lisinopril synthesis. To combat this, we recommend minimizing temperature excursions and ensuring homogeneous mixing before sampling. Our quality control includes stress testing under simulated transport conditions to guarantee that the product remains within specification throughout the supply chain.

As a manufacturer, we understand that the synthesis route for lisinopril demands high industrial purity. Our ethyl 2-oxo-4-phenylbutyrate is produced under strict process controls, and we provide comprehensive analytical support. The compound, also known as 2-oxo-4-phenylbutanoic acid ethyl ester, is a key organic building block in this pharmaceutical process. By choosing a supplier with deep field knowledge, you mitigate risks that generic distributors overlook.

Bulk Procurement and Lead Time Optimization for Ethyl 2-oxo-4-phenylbutyrate in Lisinopril Manufacturing

For supply chain directors, securing a consistent supply of ethyl 2-oxo-4-phenylbutyrate is paramount. Our manufacturing capacity allows for bulk orders with competitive lead times. Typically, we maintain safety stock of this pharmaceutical grade intermediate, enabling shipment within 2–3 weeks for standard orders. For larger volumes or custom synthesis requirements, lead times may extend, but we work closely with clients to align production schedules. We offer flexible contract terms, including annual supply agreements, to stabilize your raw material costs.

When evaluating global manufacturers, consider the total cost of ownership, not just bulk price. Our product serves as a seamless drop-in replacement for reference standards, reducing qualification time. We provide full documentation, including COA, MSDS, and batch-specific impurity profiles. This transparency is critical for regulatory compliance in API manufacturing. As a precursor in the lisinopril process, ethyl 2-oxo-4-phenylbutyrate must meet stringent quality metrics, and our track record speaks for itself.

Hazmat Compliance and Safe Handling Protocols for Ethyl 2-oxo-4-phenylbutyrate in Pharmaceutical Supply Chains

Ethyl 2-oxo-4-phenylbutyrate is classified as a hazardous chemical for transport. It is combustible and may cause skin and eye irritation. Proper labeling according to GHS standards is mandatory. Our shipments include UN-approved packaging, hazard labels, and safety data sheets. We ensure compliance with international maritime and air transport regulations. For plant managers, we recommend installing chemical pumps compatible with medium-viscosity esters; diaphragm or peristaltic pumps are suitable. Always ground and bond containers during transfer to prevent static discharge.

Personal protective equipment (PPE) should include chemical-resistant gloves, safety goggles, and protective clothing. Work areas must have adequate ventilation. In case of spillage, absorb with inert material and dispose according to local regulations. Our technical support team can assist with on-site handling training and risk assessments. By adhering to these protocols, you ensure worker safety and uninterrupted production.

Frequently Asked Questions

What are the lead times for temperature-controlled bulk shipments of ethyl 2-oxo-4-phenylbutyrate?

Standard lead time is 2–3 weeks for orders up to 500 kg, including thermal packaging preparation. For larger volumes or custom requirements, lead times may be 4–6 weeks. We coordinate with specialized logistics providers to ensure temperature-controlled containers are available, especially during winter months. Expedited shipping options are available upon request.

Are the drums compatible with standard chemical pumps used in pharmaceutical plants?

Yes, our 25kg HDPE drums and 210L steel drums are designed with standard 2-inch bung openings compatible with most diaphragm or peristaltic pumps. For IBC totes, we provide adapters as needed. The product's viscosity at recommended temperatures (15–25°C) allows for smooth pumping. If the material has been exposed to cold, ensure it is fully thawed and homogeneous before transfer.

What is the storage temperature threshold to prevent crystallization before reactor charging?

To prevent crystallization, store ethyl 2-oxo-4-phenylbutyrate above 10°C, ideally at 15–25°C. Brief excursions below 10°C may not cause immediate solidification, but prolonged exposure near 0°C will lead to crystal formation. If crystallization occurs, gently warm the sealed container to 25–30°C and agitate until clear. Never exceed 40°C to avoid degradation.

What is CAS 718 08 1 used for?

CAS 718-08-1 refers to ethyl 2-oxo-4-phenylbutyrate, a key intermediate in the synthesis of the ACE inhibitor lisinopril. It is used to introduce the phenylbutyrate moiety into the lisinopril molecule via condensation with a lysine derivative. This compound is also employed in other pharmaceutical research and custom synthesis applications.

Sourcing and Technical Support

As a dedicated manufacturer of ethyl 2-oxo-4-phenylbutyrate, NINGBO INNO PHARMCHEM combines field-proven expertise with reliable supply. Our product is a true drop-in replacement, backed by rigorous quality control and logistics know-how. Whether you need a single drum or a full container, we provide the technical support to keep your lisinopril lines running smoothly. Partner with a verified manufacturer. Connect with our procurement specialists to lock in your supply agreements.